Cellex Cell Professionals
Who we are
Cellex is a CDMO with more than 10 years’ experience in manufacturing of autologous and allogeneic cell therapy products. We are a reliable partner for four of the top 20 pharmaceutical companies and for international biotech companies, for innovative start-ups, and for academic research institutions. We can support you in all phases of preclinical testing and clinical trials, and we are a great partner for the production of cell-based therapeutics and their intermediates post-marketing authorization. We are proud to be involved in the manufacturing of 3 of the commercially approved CAR-T therapies in Europe. With more than 50 employees in Quality Management, we guarantee production under GMP conditions with consistent quality.
We also have the cutting-edge experience in cell collection and can supply all necessary starting materials for your R&D projects or clinical studies. We perform the collections in our Cellex Collection Center using established procedures and can offer individual products based on your specifications.
We organize and monitor all processes along the entire supply chain to ensure the cell products reach their destination safely, quickly, and in optimal quality.
You will also benefit from our experience in GMP-compliant processes and international regulations as part of our consulting and audit services.
Our vision/Our DNA
History
2001: Foundation of Cellex
Prof. Gerhard Ehninger, MD founded Cellex as a collection center for peripheral stem cells. Thus, he pursued the goal of securing the supply for people with leukemia, who are reliant on blood stem cells.
Until 2018, he was head of hematology and oncology at Dresden University Hospital. Under his leadership, in 1986, the first successful transplants of unrelated blood stem cells in Germany were carried out at the Tübingen Medical Clinic. In 1991, he co-founded the DKMS German Bone Marrow Donor Center gGmbH.
2009: Cellex Collection Center Cologne
Cellex opened another collection center for blood stem cells and bone marrow in the Mediapark Clinic in Cologne. Over 50,000 stem cell collections and bone marrow collections have been carried out in Cologne and Dresden since it was founded.
2013: Cellex Transport and Logistics
In 2013, Cellex expanded its scope to provide every service along the whole supply chain. Since then, we have offered fast and reliable cell transports. Whether by freight shipment or courier delivery, nationally or worldwide, Cellex has completed all the necessary approval processes and is accredited as a known consignor.
2014: Cellex enters the field of cell and gene research (CGT)
In 2014, Cellex begins developing innovative approaches for the immunotherapy of leukaemia and cancer. The first preclinical work is carried out in the field of bispecific antibodies and a novel adapter CAR-T system in Dresden. A production facility is built in Cologne to support proof-of-concept studies in academic and biotechnology companies.
2015: Cellex Foundation
In 2015 Cellex established the Cellex Foundation to promote international tolerance and encourage scientific progress based on open discussion and the cooperation of people worlwide.
2016: Cell Community
To effectively support the development of new cell therapies, Cellex began establishing a donor database in 2016 called the “Cell Community”. Its donors make it possible for Cellex to offer starting material for research, clinical trials, and commercial use.
2019: Cellex Cell Manufacturing Plant
Cellex built a state-of-the-art construction facility in Cologne-Ossendorf. At this site Cellex creates both its own products and products for customers.
2021: AvenCell Therapeutics
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics launched the CAR-T cell company AvenCell Therapeutics with registered offices in Boston and Dresden. It focuses is on the development of allogenic universal CAR-T cell therapies for immuno-oncology.
2023: Expansion of the Manufacturing Plant
We opened the third construction phase of our state-of-the-art laboratory facility in Cologne-Ossendorf.
Your contacts at Cellex
Cellex Cell Professionals
Management Team
Dr. Armin Ehninger
Managing Director
Chief Scientific & Strategic Officer (CSO)
Prof. Gerhard Ehninger
Founder and Managing Director
Chief Executive Officer (CEO)
Carla Kreissig
Managing Director
Chief Executive Officer (CEO)
Cellex Manufacturing Transports & Logistics,
Cellex Medical Services (CMO)
Business Development
Matthias Wangemann and Julie Daigre
Phone +49 221 2509 1961
businessdevelopment@cellex.me
Media Contact
Cornelia Sczepan
Manager Marketing and Communications
Phone +49 221 2509 2916
medienkontakt@cellex.me
Find out more about Cellex as a company and get in touch here.
Cellex Foundation: Science for the world
Cellex founded the Cellex Foundation in 2015 to reconcile science and research with cosmopolitanism and tolerance. The foundation has initiated multiple projects and courses which offer diverse opportunities for interpersonal encounters and to become acquainted with new perspectives. Cellex Academy supports international scientific exchange in hematology and oncology.
Careers and Cellex
Would you like to shape the future of cell therapy with us? We look forward to receiving your application!
You can find more information about working at Cellex and the current open positions here.